INDRAMEDCO360.50

Indraprastha Medical Corporation Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersARTEMISMEDSHALBYGKSLGPTHEALTHLOTUSEYEDRAGARWQKMCSHILKOVAIMcap ₹3,305 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,244.71,356.41,482.51,523.6
Other Income16.922.728.830.3
Total Income1,261.61,379.01,511.31,553.9
Expenses
+ Cost of Materials Consumed217.2230.5256.3263.6
+ Employee Benefit Expense261.6277.1287.6295.6
+ Finance Costs4.16.36.06.1
+ Depreciation & Amortisation40.144.343.645.2
+ Other Expenses572.5604.5671.7690.8
Total Expenses1,095.51,162.71,265.21,301.3
EBITDA193.4244.3266.9273.6
EBIT153.3199.9223.3228.4
Profit
PBT before Exceptional Items166.1216.3246.0252.5
Pretax Income166.1216.3246.0252.5
+ Current Tax43.059.457.960.1
+ Deferred Tax-0.9-4.14.54.4
Tax Expense42.255.362.464.5
Net Income124.0161.0183.6188.0
+ Net Income — Continuing Ops124.0161.0183.6188.0
+ Other Comprehensive Income1.9-0.81.3-0.9
Total Comprehensive Income125.8160.2184.9187.1
Per Share
Basic EPS13.5217.5620.0320.51
Diluted EPS13.5217.5620.0314.42
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.81.3-0.9
+ Items NOT to be Reclassified to P&L2.5-1.11.8-1.2
+ Tax on Items NOT to be Reclassified-0.30.4-0.3
+ Tax on Items NOT to be Reclassified — alt tag0.6
Per Share — as-filed variants
Basic EPS — Continuing Operations13.5217.5620.0320.51
Diluted EPS — Continuing Operations13.5217.5620.0314.42
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit1,027.51,125.91,226.21,260.0
Gross Margin %82.5583.0182.7182.70
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)166.1216.3246.0252.5
Net Income Adj (tax-effected)124.0161.0183.6188.0
EPS Adj13.5217.5620.0320.51
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Paid Up Equity Capital91.791.791.791.7
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.